479 related articles for article (PubMed ID: 20382885)
1. Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta.
Patel SA; Meyer JR; Greco SJ; Corcoran KE; Bryan M; Rameshwar P
J Immunol; 2010 May; 184(10):5885-94. PubMed ID: 20382885
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
3. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
[TBL] [Abstract][Full Text] [Related]
4. Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-β1 and upregulate expression of regulatory molecules on T cells: do they protect breast cancer cells from the immune response?
Razmkhah M; Jaberipour M; Erfani N; Habibagahi M; Talei AR; Ghaderi A
Cell Immunol; 2011; 266(2):116-22. PubMed ID: 20970781
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patients with chronic myeloid leukemia.
Zhao ZG; Li WM; Chen ZC; You Y; Zou P
Immunol Invest; 2008; 37(7):726-39. PubMed ID: 18821219
[TBL] [Abstract][Full Text] [Related]
6. Interactions between human mesenchymal stem cells and natural killer cells.
Sotiropoulou PA; Perez SA; Gritzapis AD; Baxevanis CN; Papamichail M
Stem Cells; 2006 Jan; 24(1):74-85. PubMed ID: 16099998
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells.
Prigione I; Benvenuto F; Bocca P; Battistini L; Uccelli A; Pistoia V
Stem Cells; 2009 Mar; 27(3):693-702. PubMed ID: 19096038
[TBL] [Abstract][Full Text] [Related]
8. Immune protection function of multipotent mesenchymal stromal cells: role of transforming growth factor-β1.
Zhao ZG; Cao Z; Xu W; Sun L; You Y; Li F; Li QB; Zou P
Cancer Invest; 2012 Nov; 30(9):646-56. PubMed ID: 23020627
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal cells inhibit expansion but not cytotoxicity exerted by gamma-delta T cells.
Petrini I; Pacini S; Petrini M; Fazzi R; Trombi L; Galimberti S
Eur J Clin Invest; 2009 Sep; 39(9):813-8. PubMed ID: 19522834
[TBL] [Abstract][Full Text] [Related]
10. Functional and phenotypic alteration of intrasplenic lymphocytes affected by mesenchymal stem cells in a murine allosplenocyte transfusion model.
Li H; Guo ZK; Li XS; Hou CM; Tang PH; Mao N
Cell Transplant; 2007; 16(1):85-95. PubMed ID: 17436858
[TBL] [Abstract][Full Text] [Related]
11. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
Arteaga CL; Hurd SD; Winnier AR; Johnson MD; Fendly BM; Forbes JT
J Clin Invest; 1993 Dec; 92(6):2569-76. PubMed ID: 7504687
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow mesenchymal stem cells reduce the antitumor activity of cytokine-induced killer/natural killer cells in K562 NOD/SCID mice.
Li Y; Qu YH; Wu YF; Wang XP; Wei J; Huang WG; Zhou DH; Fang J; Huang K; Huang SL
Ann Hematol; 2011 Aug; 90(8):873-85. PubMed ID: 21234566
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive effects of rat mesenchymal stem cells: involvement of CD4+CD25+ regulatory T cells.
Ye Z; Wang Y; Xie HY; Zheng SS
Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):608-14. PubMed ID: 19073406
[TBL] [Abstract][Full Text] [Related]
14. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
Herrmann JL; Wang Y; Abarbanell AM; Weil BR; Tan J; Meldrum DR
Shock; 2010 Jan; 33(1):24-30. PubMed ID: 19996917
[TBL] [Abstract][Full Text] [Related]
15. Early detection of tumor cells by innate immune cells leads to T(reg) recruitment through CCL22 production by tumor cells.
Faget J; Biota C; Bachelot T; Gobert M; Treilleux I; Goutagny N; Durand I; Léon-Goddard S; Blay JY; Caux C; Ménétrier-Caux C
Cancer Res; 2011 Oct; 71(19):6143-52. PubMed ID: 21852386
[TBL] [Abstract][Full Text] [Related]
16. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells.
DelaRosa O; Lombardo E; Beraza A; Mancheño-Corvo P; Ramirez C; Menta R; Rico L; Camarillo E; García L; Abad JL; Trigueros C; Delgado M; Büscher D
Tissue Eng Part A; 2009 Oct; 15(10):2795-806. PubMed ID: 19231921
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells.
Xu G; Zhang L; Ren G; Yuan Z; Zhang Y; Zhao RC; Shi Y
Cell Res; 2007 Mar; 17(3):240-8. PubMed ID: 17325691
[TBL] [Abstract][Full Text] [Related]
18. Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation.
Carrión F; Nova E; Luz P; Apablaza F; Figueroa F
Immunol Lett; 2011 Mar; 135(1-2):10-6. PubMed ID: 20888363
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells contribute to the abnormal bone marrow microenvironment in patients with chronic idiopathic neutropenia by overproduction of transforming growth factor-β1.
Stavroulaki E; Kastrinaki MC; Pontikoglou C; Eliopoulos D; Damianaki A; Mavroudi I; Pyrovolaki K; Katonis P; Papadaki HA
Stem Cells Dev; 2011 Aug; 20(8):1309-18. PubMed ID: 21047210
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cell-mediated immature dendritic cells induce regulatory T cell-based immunosuppressive effect.
Choi YS; Jeong JA; Lim DS
Immunol Invest; 2012; 41(2):214-29. PubMed ID: 22017637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
